02
Feb
2012
02
Feb
2012
31
Jan
2012
26
Jan
2012
Posted in I - Series B, Q - 3Q11, R - MID WEST, X - Device (Diagnostic), X - Oncology, XX - MI
Intervention Insights (Grand Rapids, MI) a commercial-stage personalized medicine company focused on molecularly targeted oncology therapies, closed a $7.2M Series B financing. Participants include Beringea, Chrysalis Ventures, Hopen Life Science Ventures and Michigan Accelerator Fund.
Thanx for your patience as we catch-up.
23
Jan
2012
Posted in I - Series B, Q - 3Q11, R - MID WEST, X - Biomarker, X - Device (Diagnostic), XX - OH
Cleveland Heartlab (Cleveland, OH) a commercial-stage specialty clinical laboratory and disease management company focused on assessing cardiovascular risk, closed a $18.4M Series B financing. Participants include Excel Venture Management and HealthCare Ventures.
Thanx for your patience as we catch-up.
12
Jan
2012
10
Jan
2012
Posted in I - Series A, Q - 3Q11, R - MID WEST, X - Wound Healing, XX - OH
SironRx Therapeutics (Cleveland, OH) a clinical-stage regenerative therapy company focused on wound repair and scarring prevention, closed a $3.4M Series A financing. Participants include North Coast Angel Fund, Cleveland Clinic, JumpStart, Fletcher Spaght Investments, Glengary, Ohio Tech Angel Fund and Early Stage Partners.
Thanx for your patience as we catch-up.
09
Jan
2012
Posted in I - Series F, Q - 3Q11, R - MID WEST, X – Device (Sinusitis), XX - MN
Entellus Medical (Maple Grove, MN) a commercial-stage medical device company focused on minimally invasive treatments for chronic sinusitis, closed a $35M Series E financing. Participants include Covidien Ventures, SV Life Sciences, Essex Woodlands, Split Rock Partners and Greenspring Associates.
Thanx for your patience as we catch-up.
10
Nov
2011
05
Aug
2011
Posted in I - Series C, Q - 2Q11, R - MID WEST, X - TeleMedicine, XX - OH
Explorys (Cleveland, OH) a development-stage medical informatics company focused on a patient population, treatment protocols and clinical outcomes intelligence platform,closed a $11.5M Series C financing. Participants include Austin Ventures, Foundation Medical Partners, Santé Ventures and Cleveland Clinic.
04
Aug
2011
29
Jul
2011
27
Jul
2011
Posted in I - Series A, Q - 2Q11, R - MID WEST, X - CNS, X - Depression, XX - IL
Naurex (Evanston, IL) a clinical-stage pharmaceutical company focused on depression and other CNS-related disorders, closed a $18M Series A financing. Participants include Adams Street Partners, Latterell Venture Partners, Druid BioVentures, Genesys Capital, PathoCapital, Lundbeck, Takeda Ventures and Shire.